World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03220841
Date of registration: 06/07/2017
Prospective Registration: Yes
Primary sponsor: St Vincent's Hospital Melbourne
Public title: Stricture Definition and Treatment (STRIDENT) Drug Therapy Study STRIDENT
Scientific title: Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
Date of first enrolment: October 9, 2017
Target sample size: 78
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT03220841
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
Australia
Contacts
Name:     Emily Wright, MBBS PhD
Address: 
Telephone:
Email:
Affiliation:  St Vincent's Hospital Melbourne
Name:     Bronte Holt, MBBS PhD
Address: 
Telephone:
Email:
Affiliation:  St Vincent's Hospital Melbourne
Name:     Michael Kamm, MBBS PhD
Address: 
Telephone:
Email:
Affiliation:  St Vincent's Hospital Melbourne
Key inclusion & exclusion criteria

Inclusion Criteria:

- Inflammatory bowel disease patients with intestinal stricture(s) identified on CT, MRI
or endoscopy.

Exclusion Criteria:

- Acute bowel obstruction requiring urgent surgical intervention

- Deemed by treating physician to have high risk of acute bowel obstruction

- Concurrent active perianal sepsis

- Internal fistulising disease in association with strictures (entero-enteric stulas)

- Low rectal or anal strictures

- Evidence of dysplasia or malignancy from stricture biopsies or adjacent mucosal
biopsies

- Patients for whom endoscopy is not suitable due to co-morbidities or clinical state

- Inability to give informed consent

- Suspected perforation of the gastrointestinal tract

- Pregnancy

- Inability to undergo MRI small bowel due to a contraindication.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Stricture; Bowel
Crohn Disease
Inflammatory Bowel Diseases
Intervention(s)
Procedure: Endoscopic balloon dilatation
Drug: Thiopurine
Drug: Adalimumab Injection
Primary Outcome(s)
Improvement in obstructive symptoms. [Time Frame: 12 months]
Secondary Outcome(s)
Improvement in imaging parameters (Intestinal ultrasound) [Time Frame: 12 months]
Improvement in symptoms [Time Frame: 4, 8 and 12 months]
Improvement in biochemical inflammatory parameters [Time Frame: 12 months]
Improvement in imaging parameters [Time Frame: 12 months]
Improvement in patient reported outcomes (PROs) [Time Frame: 12 months]
Surgery [Time Frame: 12 months]
Secondary ID(s)
StVincentsMelbourneSTRIDENT1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Australasian Gastro Intestinal Research Foundation
AbbVie
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history